Encompass Health Corporation (EHC)
NYSE: EHC · Real-Time Price · USD
105.99
+1.23 (1.17%)
At close: May 20, 2026, 4:00 PM EDT
105.99
0.00 (0.00%)
After-hours: May 20, 2026, 7:00 PM EDT
Encompass Health Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, Encompass Health stock has a consensus rating of "Strong Buy" and an average price target of $140.64. The average 1-year stock price forecast is 32.69% higher than the current stock price, while the lowest is $130 (+22.65%) and the highest is $150 (+41.52%).
Price Target: $140.64 (+32.69%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Encompass Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 4 | 4 | 4 | 4 | 4 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $153 → $140 | Buy | Maintains | $153 → $140 | +32.09% | May 5, 2026 |
| Barclays | Barclays | Buy Maintains $150 → $153 | Buy | Maintains | $150 → $153 | +44.35% | Feb 6, 2026 |
| Barclays | Barclays | Buy Maintains $141 → $150 | Buy | Maintains | $141 → $150 | +41.52% | Oct 30, 2025 |
| UBS | UBS | Strong Buy Maintains $140 → $150 | Strong Buy | Maintains | $140 → $150 | +41.52% | Oct 2, 2025 |
| Keybanc | Keybanc | Buy Maintains $135 → $140 | Buy | Maintains | $135 → $140 | +32.09% | Sep 16, 2025 |
Financial Forecast
Revenue This Year
6.49B
from 5.94B
Increased by 9.31%
Revenue Next Year
7.02B
from 6.49B
Increased by 8.15%
EPS This Year
6.10
from 5.54
Increased by 10.08%
EPS Next Year
6.61
from 6.10
Increased by 8.34%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 6.8B | 7.4B | ||
| Avg | 6.5B | 7.0B | ||
| Low | 6.3B | 6.8B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 13.8% | 13.3% | ||
| Avg | 9.3% | 8.2% | ||
| Low | 5.9% | 4.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 6.43 | 7.05 | ||
| Avg | 6.10 | 6.61 | ||
| Low | 5.84 | 6.03 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 16.0% | 15.5% | ||
| Avg | 10.1% | 8.3% | ||
| Low | 5.4% | -1.1% |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.